Brief: Implantica Q4 EBIT Loss Widens To EUR 7.2 Million
14/02/2025 07:17
Feb 14 (Reuters) - Implantica AG 8IM1q.F :
* Q4 NET SALES DECREASED BY 13% TO EUR 442,000 (508,000)
(DUE TO
STUDY/TEST UNITS)
* Q4 OPERATING LOSS (EBIT) INCREASED TO EUR 7.2 MILLION
VERSUS
LOSS EUR 6.9 MILLION YEAR AGO
Source text: ID:nWkr6t099w
Further company coverage: 8IM1q.F
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Implantica AG
See all newsBrief: Implantica Q1 Operating Loss At EUR 3.9 Mln
Brief: Implantica Gives Final Response To FDA For PMA Application
Brief: Implantica Announces Adoption Of Refluxstop At Careggi University Hospital
Brief: Implantica - FDA Provides Feedback On Refluxstop PMA Module 3
Brief: Implantica Says FDA Provides Favorable Feedback On Refluxstop Pma Module 3